Safety of MR contrast media.
Olukotun
A Y
AY
D016907:Adverse Drug Reaction Reporting Systems; D003287:Contrast Media / Q000009:adverse effects*; D005682:Gadolinium; D006571:Heterocyclic Compounds / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D009942:Organometallic Compounds / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium